Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXK2II
|
||||
Drug Name |
1-{3-[4-(8-Chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperazine-1-carbonyl]-piperidin-1-yl}-ethanone
|
||||
Synonyms |
CHEMBL353280
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H31ClN4O2
|
||||
Canonical SMILES |
CC(=O)N1CCCC(C1)C(=O)N2CCN(CC2)C3c4ccc(Cl)cc4CCc5cccnc35
|
||||
InChI |
InChI=1S/C26H31ClN4O2/c1-18(32)31-11-3-5-21(17-31)26(33)30-14-12-29(13-15-30)25-23-9-8-22(27)16-20(23)7-6-19-4-2-10-28-24(19)25/h2,4,8-10,16,21,25H,3,5-7,11-15,17H2,1H3
|
||||
InChIKey |
XIXHYXVYAJENTI-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.